Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data

Bioinformatics

Volumn 25, Issue 2, 2009, Pages 251-257

  Barkauskas, Donald A ^a   An, Hyun Joo ^a   Kronewitter, Scott R ^a   De Leoz, Maria Lorna ^a   Chew, Helen K ^a   De Vere White, Ralph W ^a   Leiserowitz, Gary S ^a   Miyamoto, Suzanne ^a   Lebrilla, Carlito B ^a   Rocke, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; TUMOR MARKER;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DATA BASE; FEMALE; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STRUCTURAL HOMOLOGY;

ALGORITHMS; CYCLOTRONS; FOURIER ANALYSIS; HUMANS; NEOPLASMS; POLYSACCHARIDES; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 58349085340     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btn610     Document Type: Article

References (15)

1. An,H.J. et al. (2006) Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J. Proteome Res., 5, 1626-1635.
2. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B, 57, 289-300.
3. Brockhausen,I. (1999) Pathways of O-glycan biosynthesis in cancer cells. Bba-Gen Subj., 1473, 67-95.
4. Dall'Olio,F. et al. (2001) Biosynthesis of the cancer-related sialyl-α2,6-lactosaminyl epitope in colon cancer cell lines expressing β-galactoside α2,6-sialyltransferase under a constitutive promoter. Eur. J. Biochem., 268, 5876-5884.
5. Dennis,J.W. et al. (1999) Protein glycosylation in development and disease. BioEssays, 21, 412-421.
6. Gorelik,E. et al. (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev., 20, 245-277.
7. Herbert,C.G. and Johnstone,R.A. (2003) Mass Spectrometry Basics. CRC Press, Boca Raton, FL.
8. Hollingsworth,M.A. and Swanson,B.J. (2004) Mucins in cancer: Protection and control of the cell surface. Nat. Rev. Cancer, 4, 45-60.
9. Leiserowitz,G.S. et al. (2008) Glycomics analysis of serum: A potential new biomarker for ovarian cancer? Int. J. Gynecol. Cancer, 18, 470-475. Malykh,Y.N. et al. (2001) N-glycolylneuraminic acid in human tumours. Biochimie, 83, 623-634.
10. Park,Y. and Lebrilla,C.B. (2005) Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides. Mass Spectrom Rev., 24, 232-264.
11. Varki,A. (2001) N-glycolylneuraminic acid deficiency in humans. Biochimie, 83, 615-622.
12. Villanueva,J. et al. (2005) Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res., 4, 1060-1072.
13. Xi,Y. and Rocke,D.M. (2008) Baseline correction forNMRspectroscopic metabolomics data analysis. BMC Bioinformatics, 9, 324.
14. Yamori,T. et al. (1987) Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases. Cancer Res., 47, 2741-2747.
15. Zhang,L.-K. et al. (2005) Gross. Accurate mass measurements by Fourier transform mass spectrometry. Mass Spectrom. Rev., 24 286-309.